Bigul

AARTI INDUSTRIES LTD. - 524208 - Earnings Call Transcript

Transcript of Q1 FY23 Earnings Conference Call
18-08-2022
Bigul

AARTI INDUSTRIES LTD. - 524208 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of SEBI (LODR) Regulations, 2015
12-08-2022
Bigul

AARTI INDUSTRIES LTD. - 524208 - Recording Of Conference Call

Recording of Conference Call
11-08-2022
Bigul

Q1FY23 Quarterly Result Announced for Aarti Industries Ltd.

Specialty Chemicals firm Aarti Industries announced Q1FY23 Result : Significant increase in revenues was on account of pass-on for the elevated Inputs prices, Utility costs and Logistics costs. Commenced commercial production at the new block of the USFDA approved API facility at Tarapur in early Q2; this will further strengthen Company’s niche offerings in Pharma The project related to 1st and 2nd long term contract has started seeing volume ramp up; utilisation levels expected to increase to ~70%+ by the end of FY24 Revenues of Rs. 2,173 crore; increase of 45% over previous year EBITDA of Rs. 369 crore; growth of 18% over previous year PAT of Rs. 189 crore; up by 15% over previous year Commenting on the performance for Q1 FY23, Mr. Rajendra Gogri – Chairman & MD at Aarti Industries Limited said: “I am pleased to share that we started the new financial year on an encouraging note with healthy topline growth of 45% YoY and EBITDA improvement of 18% YoY in Q1 of FY23. This strong performance has come on the back of challenging operating environment premised on continued inflationary pressure in key raw materials and other utilities combined with logistical disruptions and global uncertainties. The global inflationary trend and recession fears have resulted in modest slowdown in demand from some end user segments. Given this backdrop, our performance has been resilient, and I would like to congratulate our workforce for demonstrating agility and traversing through these pressures to deliver stellar performance in a tough environment. We remain committed to drive over businesses through challenging situations and deliver robust performances. Based on strong business visibility, we had charted our growth plans and CAPEX deployment is underway to accomplish our longterm goals. We will see new capacities being commissioned in a phase-wise manner from this financial year that will elevate our performance trajectory. In addition, we are also expanding our product portfolio, introducing new high-potential and complex chemical value-chains, and strengthening our R&D; capabilities to cement our leadership position in the chosen chemistries. Our planned investments close to ~Rs. 3,000 crore in the over two years are on track, that will define our growth strategy. Overall, we are well placed to capture incremental market share based on our superior execution capabilities combined with planned scale-up for key products and addition of niche chemical value-chains. We strongly believe in the growth potential of the Indian Chemical & Pharma industry and will endeavor to make significant inroads to deliver sustained profitability.” Result PDF
11-08-2022
Bigul

AARTI INDUSTRIES LTD. - 524208 - Announcement under Regulation 30 (LODR)-Investor Presentation

Please find enclosed herewith the Q1 FY23 Results Presentation of the Company for your records.
11-08-2022
Bigul

AARTI INDUSTRIES LTD. - 524208 - Audited Financial Results For The Quarter Ended June 30, 2022

Audited Financial Results for the quarter ended June 30, 2022
10-08-2022
Bigul

AARTI INDUSTRIES LTD. - 524208 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Company has issued the Letter of Confirmation in lieu of Duplicate Share Certificate.
09-08-2022
Bigul

AARTI INDUSTRIES LTD. - 524208 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

This has reference to our earlier Intimation dated August 4, 2022, this is to state that the Quarterly Earnings Call for Investors and Analysts has been scheduled on Thursday, August 11, 2022 at 4:30 p.m. to discuss the Company''s Q1 FY23 Results. Please find attached herewith invitation for the same and the weblink for Pre-registration for the Conference Call.
05-08-2022
Bigul

AARTI INDUSTRIES LTD. - 524208 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

This is to state that the Quarterly Earnings Call for Investors and Analysts has been scheduled on Thursday, August 11, 2022 at 4:30 p.m. to discuss the Company''s Q1 FY23 Results.
04-08-2022
Bigul

AARTI INDUSTRIES LTD. - 524208 - Board Meeting Intimation for Audited Financial Results For The Quarter Ended June 30, 2022

AARTI INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 ,inter alia, to consider and approve and take on record Audited Financial Results for the quarter ended June 30, 2022
02-08-2022
Next Page
Close

Let's Open Free Demat Account